Geode Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
|
|||||
|
2025
Q1 | $10.4M | Buy |
|
|||||
|
2024
Q4 | $6.83M | Buy |
|
|||||
|
2024
Q3 | $8.98M | Buy |
|
|||||
|
2024
Q2 | $13.5M | Buy |
|
|||||
|
2024
Q1 | $22.3M | Buy |
|
|||||
|
2023
Q4 | $25.3M | Buy |
|
|||||
|
2023
Q3 | $22.8M | Buy |
|
|||||
|
2023
Q2 | $50.2M | Buy |
|
|||||
|
2023
Q1 | $43.6M | Buy |
|
|||||
|
2022
Q4 | $38.4M | Buy |
|
|||||
|
2022
Q3 | $37.7M | Buy |
|
|||||
|
2022
Q2 | $30.8M | Buy |
|
|||||
|
2022
Q1 | $23.7M | Sell |
|
|||||
|
2021
Q4 | $38.6M | Buy |
|
|||||
|
2021
Q3 | $38.8M | Buy |
|
|||||
|
2021
Q2 | $44M | Buy |
|
|||||
|
2021
Q1 | $49.2M | Buy |
|
|||||
|
2020
Q4 | $55.2M | Buy |
|
|||||
|
2020
Q3 | $36.8M | Sell |
|
|||||
|
2020
Q2 | $25.8M | Buy |
|
|||||
|
2020
Q1 | $17.1M | Buy |
|
|||||
|
2019
Q4 | $41.3M | Buy |
|
|||||
|
2019
Q3 | $77.6M | Buy |
|
|||||
|
2019
Q2 | $100M | Buy |
|
|||||
|
2019
Q1 | $83.5M | Buy |
|
|||||
|
2018
Q4 | $44.8M | Buy |
|
|||||
|
2018
Q3 | $61.6M | Buy |
|
|||||
|
2018
Q2 | $68.1M | Buy |
|
|||||
|
2018
Q1 | $68.9M | Buy |
|
|||||
|
2017
Q4 | $62.7M | Buy |
|
|||||
|
2017
Q3 | $19.2M | Buy |
|
|||||
|
2017
Q2 | $23.3M | Buy |
|
|||||
|
2017
Q1 | $19M | Buy |
|
|||||
|
2016
Q4 | $12.5M | Buy |
|
|||||
|
2016
Q3 | $10.4M | Buy |
|
|||||
|
2016
Q2 | $4.24M | Buy |
|
|||||
|
2016
Q1 | $3.84K | Buy |
|
|||||
|
2015
Q4 | $4.7M | Buy |
|
|||||
|
2015
Q3 | $3.19M | Buy |
|
|||||
|
2015
Q2 | $5.32M | Buy |
|
|||||
|
2015
Q1 | $1.9M | Buy |
|
|||||
|
2014
Q4 | $1.27M | Buy |
|
|||||
|
2014
Q3 | $778K | Buy |
|